News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Stallergenes, S.A. (GENP.PA) Expands Latin American Presence With Acquisition Of Alergo Pharma S.R.L. In Argentina


7/21/2014 12:30:34 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ANTONY, France--(BUSINESS WIRE)--STALLERGENES (Paris:GENP), a global healthcare company specialized in the diagnosis and treatment of allergies through allergen immunotherapy-based solutions, announced today the acquisition of the entire share capital of ALERGO PHARMA S.R.L., an Argentinean allergen immunotherapy (AIT) company.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES